HOME >> BIOLOGY >> NEWS
Dinosaur symposium at the Smithsonian Institution

The Smithsonian's National Museum of Natural History will host "Dinosaurs in the New Millennium," the museum's first symposium on dinosaur science, Saturday and Sunday, Dec. 13-14. All events are free and open to the public and will be held in the Museum's Baird Auditorium. Scientists, dinosaur enthusiasts and families are all invited to attend.

The public symposium, organized and hosted by Smithsonian dinosaur curator Dr. Matthew Carrano, will present speakers from 11 universities and museums around the world. They will discuss a wide variety of topics in dinosaur science including dinosaur growth, diet and health, as well as the world in which they lived.

On Dec. 13, experts will discuss various aspects of dinosaur biology and present a roadmap for new theories and discoveries in the coming decades. Several of the 30-minute talks will be followed by a question-and-answer session. The lectures begin at 9 a.m. and continue until 4:45 p.m.

On Dec. 14, world-famous dinosaur paleontologist Jack Horner will kick off the second day of the symposium with the keynote speech at noon. Horner is the curator of paleontology at the Museum of the Rockies in Bozeman, MT. He is also a senior scholar at the Smithsonian Institution. His talk, "Dinosaur Science in the 21st Century," will be followed by a moderated roundtable discussion.

From 3-5 p.m., Smithsonian paleontologists will give a series of talks about "The World of Dinosaurs." These talks will cover topics ranging from the origin of flowers, ancient plants and flowers, prehistoric insects, and the extinction of dinosaurs.

Visitors may also enjoy the museum's Dinosaur Hall, eating at the Fossil Caf, or shopping at the TriceraShop, a special museum shop devoted to dinosaur-related toys, clothing, books and more.

The Smithsonian's National Museum of Natural History is located at 10th Street and Constitution Ave, N.W. in Washington, D.C. Museum hours are 10 a.m. -
'"/>

Contact: Michele Urie
urie.michele@nmnh.si.edu
202-786-2950
Smithsonian Tropical Research Institute
8-Dec-2003


Page: 1 2

Related biology news :

1. Dinosaur fossil record compiled, analyzed
2. Dinosaur, crab fossils reveal ecosystem secrets
3. Dinosaur ancestors vision possibly nocturnal
4. Dinosaur discoveries in Montana
5. Dinosaurs had a "rostral nostril," says Science researcher
6. Dinosaurs large noses may have been key to physiological processes
7. Dinosaurs: New study counters age-old theory
8. Dinosaur fossils reveal evolutions big picture, says Paul Sereno
9. Dinosaurs And Neanderthals
10. Fossil Footprints Show Foot-Movement Similarity In Dinosaurs And Birds
11. Montana Scientist Returns From Dinosaur Nesting Site In Patagonia

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dinosaur symposium the Smithsonian Institution

(Date:12/10/2014)... 08, 2014 Research and Markets ... the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of ... rural banking and upgradation of the driver,s license ... the market. Besides the aforementioned projects, biometrics is ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
(Date:12/4/2014)... 3, 2014  Crossmatch™, a leading provider of ... DigitalPersona ® Pro Enterprise software and U.are.U ... throughout First Bank branch locations in ... and Virginia. First Bank, a progressive community ... North Carolina , selected the Crossmatch biometrics-based ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... 17, 2014 Audacity, a leading California-based ... member of the Huntsworth Health Group, is proud to ... team. In her role, Gonzales will serve as Senior ... incredibly honored to welcome a talent of Jamie’s caliber ... Gaëtan Fraikin. “She is a proven healthcare innovation leader ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: